Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP2637670 | Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains | AMGEN RESEARCH (MUNICH) GMBH | Dec 7, 2017 |
Patent Number | Grant Date | Title | Total Oppositions |
---|---|---|---|
EP3177645 | Feb 17, 2021 | Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer | 10 |
Feel free to send us a message here and we will get back to you